BioRestorative Therapies (BRTX) Share-based Compensation (2016 - 2025)
Historic Share-based Compensation for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $399932.0.
- BioRestorative Therapies' Share-based Compensation rose 4069.97% to $399932.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 2555.15%. This contributed to the annual value of $2.8 million for FY2024, which is 6386.25% down from last year.
- Per BioRestorative Therapies' latest filing, its Share-based Compensation stood at $399932.0 for Q3 2025, which was up 4069.97% from $468708.0 recorded in Q2 2025.
- In the past 5 years, BioRestorative Therapies' Share-based Compensation ranged from a high of $14.1 million in Q1 2021 and a low of $175625.0 during Q4 2024
- In the last 5 years, BioRestorative Therapies' Share-based Compensation had a median value of $2.0 million in 2025 and averaged $2.5 million.
- Per our database at Business Quant, BioRestorative Therapies' Share-based Compensation skyrocketed by 624428.68% in 2021 and then tumbled by 8800.71% in 2024.
- BioRestorative Therapies' Share-based Compensation (Quarter) stood at $3.2 million in 2021, then decreased by 4.7% to $3.1 million in 2022, then plummeted by 52.12% to $1.5 million in 2023, then crashed by 88.01% to $175625.0 in 2024, then skyrocketed by 127.72% to $399932.0 in 2025.
- Its last three reported values are $399932.0 in Q3 2025, $468708.0 for Q2 2025, and $2.0 million during Q1 2025.